These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Resistance to antiretroviral drugs: a threat to the prevention and treatment of pediatric HIV infection. Krogstad PA J Infect Dis; 2007 May; 195(10):1393-5. PubMed ID: 17436216 [No Abstract] [Full Text] [Related]
25. Antiretroviral basics. Miller N Midwifery Today Int Midwife; 2005; (73):30-4. PubMed ID: 15835846 [No Abstract] [Full Text] [Related]
26. Management of HIV: a swing back to the future. Alozie OK; Bonham S; Henry WK Minn Med; 2009 Oct; 92(10):45-9. PubMed ID: 19916274 [TBL] [Abstract][Full Text] [Related]
27. [HIV-infection: modern antiretroviral therapy]. Rockstroh JK; Spengler U Dtsch Med Wochenschr; 2004 Sep; 129(37):1921-4. PubMed ID: 15372371 [No Abstract] [Full Text] [Related]
28. The safety of highly active antiretroviral therapy for the HIV-positive pregnant mother and her baby: is 'the more the merrier'? Martin F; Taylor GP J Antimicrob Chemother; 2009 Nov; 64(5):895-900. PubMed ID: 19706669 [TBL] [Abstract][Full Text] [Related]
29. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. Warszawski J; Tubiana R; Le Chenadec J; Blanche S; Teglas JP; Dollfus C; Faye A; Burgard M; Rouzioux C; Mandelbrot L; AIDS; 2008 Jan; 22(2):289-99. PubMed ID: 18097232 [TBL] [Abstract][Full Text] [Related]
30. Genotypic resistance tests for the management of the HIV-infected pregnant patient in Africa. Giaquinto C Scand J Infect Dis Suppl; 2003; 106():88-90. PubMed ID: 15000594 [TBL] [Abstract][Full Text] [Related]
31. Increased rates of preterm delivery are associated with the initiation of highly active antiretrovial therapy during pregnancy: a single-center cohort study. Martin F; Taylor GP J Infect Dis; 2007 Aug; 196(4):558-61. PubMed ID: 17624841 [TBL] [Abstract][Full Text] [Related]
32. The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa. Hamers RL; Derdelinckx I; van Vugt M; Stevens W; Rinke de Wit TF; Schuurman R; Antivir Ther; 2008; 13(5):625-39. PubMed ID: 18771046 [TBL] [Abstract][Full Text] [Related]
33. HIV transmission. Allegations raise fears of backlash against AIDS prevention strategy. Cohen J Science; 2004 Dec; 306(5705):2168-9. PubMed ID: 15618490 [No Abstract] [Full Text] [Related]
34. [GESIDA survey on antiretroviral treatment in 1998. Working Group for the Study of AIDS (GESIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)]. Miró JM; Arrizabalaga J; Gatell JM Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():69-70. PubMed ID: 9859622 [No Abstract] [Full Text] [Related]
35. [Reducing perinatal transmission by antiretroviral therapy]. Schmied B Wien Med Wochenschr; 1998; 148(23-24):550-5. PubMed ID: 10189685 [TBL] [Abstract][Full Text] [Related]
36. Start anti-HIV treatment early, in adults and infants. Laurence J AIDS Read; 2009 Jan; 19(1):6-7, 17. PubMed ID: 19209449 [No Abstract] [Full Text] [Related]
37. AIDS conference data on children. Vazquez E Posit Aware; 1998; 9(5):58-9. PubMed ID: 11365899 [TBL] [Abstract][Full Text] [Related]
38. Perinatal HIV prevention aims for elimination. AIDS Read; 2002 Apr; 12(4):146, 150. PubMed ID: 12071183 [No Abstract] [Full Text] [Related]
39. HIV/AIDS. ARVs as HIV prevention: a tough road to wide impact. Shelton JD Science; 2011 Dec; 334(6063):1645-6. PubMed ID: 22194560 [No Abstract] [Full Text] [Related]
40. Honing the test-and-treat HIV strategy. Mastro TD; Cohen MS Science; 2010 May; 328(5981):976. PubMed ID: 20489007 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]